Information title
Bevacizumab-Erlotinib Combination May Improve Progression-Free Survival in Advanced Non-Small Cell Lung Cancer Patients
Published on Saturday 22 November 2008 - 11:39 Summary :
Combination treatment with bevacizumab (AVASTIN® | Genentech, Inc.) and erlotinib (Tarceva® | OSI Pharmaceuticals, Inc., Genentech, Inc.) increases the progression-free survival and objective...
Read more
MediNEWS.Direct!
http://www.medinewsdirect.com Website description
Medical NEWS You Can Digest!
